Correlation Between Seres Therapeutics and Oxford BioDynamics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Oxford BioDynamics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Oxford BioDynamics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Oxford BioDynamics Plc, you can compare the effects of market volatilities on Seres Therapeutics and Oxford BioDynamics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Oxford BioDynamics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Oxford BioDynamics.

Diversification Opportunities for Seres Therapeutics and Oxford BioDynamics

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Seres and Oxford is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Oxford BioDynamics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford BioDynamics Plc and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Oxford BioDynamics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford BioDynamics Plc has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Oxford BioDynamics go up and down completely randomly.

Pair Corralation between Seres Therapeutics and Oxford BioDynamics

Given the investment horizon of 90 days Seres Therapeutics is expected to generate 0.75 times more return on investment than Oxford BioDynamics. However, Seres Therapeutics is 1.34 times less risky than Oxford BioDynamics. It trades about 0.18 of its potential returns per unit of risk. Oxford BioDynamics Plc is currently generating about -0.21 per unit of risk. If you would invest  66.00  in Seres Therapeutics on September 13, 2024 and sell it today you would earn a total of  20.05  from holding Seres Therapeutics or generate 30.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Seres Therapeutics  vs.  Oxford BioDynamics Plc

 Performance 
       Timeline  
Seres Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Seres Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Seres Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Oxford BioDynamics Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford BioDynamics Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Seres Therapeutics and Oxford BioDynamics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seres Therapeutics and Oxford BioDynamics

The main advantage of trading using opposite Seres Therapeutics and Oxford BioDynamics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Oxford BioDynamics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford BioDynamics will offset losses from the drop in Oxford BioDynamics' long position.
The idea behind Seres Therapeutics and Oxford BioDynamics Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum